EXMED WORLDWIDE LIMITEDActive
Key figures
Like most small UK companies, EXMED WORLDWIDE LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2023/24Balance sheet structure
Filed accounts2019/20–2023/24
| 2019/20 | 2020/21 | 2021/22 | 2022/23 | 2023/24 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 65,772 | 15,785 | 53,999 | 89,521 | 2,427 |
| Total assets | 4,026,716 | 2,834,642 | 2,642,459 | 2,873,349 | 2,363,432 |
| Total liabilities | — | — | — | — | 1,235,561 |
| Net assets / total equity | 58,673 | 240,395 | 329,592 | 1,138,646 | 1,121,621 |
| Average number of employees | 8 | 8 | 7 | 10 | 12 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: EXMED WORLDWIDE LIMITED
Company
EXMED WORLDWIDE LIMITED is a private limited company registered with Companies House under company number 10833667. It was incorporated on 23 Jun 2017. Its status is active. The registered office is in St helens (WA10). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).
Accounts
The latest accounts in the database are for 2023/24 (period ending 30 Sep 2024); the company files small company accounts (filleted). Net assets were £1,121,621, down 1.5% on the previous year. Cash at bank and in hand was £2,427. Total assets were £2,363,432 and total liabilities £1,235,561. The company had an average of 12 employees. Figures are available for 5 financial years (2019/20–2023/24).
Control and charges
2 persons with significant control are registered. 1 of 3 registered charges are outstanding.
Filing deadlines
The next accounts are due by 29 Jun 2027. The next confirmation statement is due by 12 Mar 2027.